The combination of PP2 with AG9 or AG490 led to the induction of unspecific toxicity in CLL cells, making it impossible for assessing the additive effects of JAKs and Src inhibitors on IFN-mediated cell survival. The gene discussed is IFNA1; the disease is B-cell chronic lymphocytic leukemia.